Journal of the National Cancer Institute Advance Access originally published online on June 24, 2008
JNCI Journal of the National Cancer Institute 2008 100(13):972; doi:10.1093/jnci/djn159
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press.
CORRESPONDENCE |
Re: The Association Between Statins and Cancer Incidence in a Veterans Population
Correspondence to: Elizabeth A. Platz, ScD, MPH, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; the James Buchan Brady Urological Institute and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, 615 N Wolfe St, Rm E6132, Baltimore, MD 21205 (e-mail: eplatz@jhsph.edu).
| The first 10% of the full text of this article appears below. |
I was pleased to read the article by Farwell et al. (1) reporting on statins and cancer. By comparing cancer incidence rates in statin users (irrespective of antihypertensive drug use) and antihypertensive drug users, the investigators likely limited detection bias that can arise in studies in which opportunity for exposure and
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 973-974.
This article has been cited by other articles:
![]() |
L. Mascitelli, U. Ravnskov, F. Pezzetta, and M. R. Goldstein After the Failure of ENHANCEd Cholesterol Lowering in Familial Hypercholesterolemia, SEAS of Problems with Ezetimibe Angiology, February 1, 2009; 60(1): 127 - 128. [PDF] |
||||
